Selective lesion of the cholinergic basal forebrain causes a loss of cortical neuropeptide Y and somatostatin neurons

Brain Research

Volumn 800, Issue 2, 1998, Pages 198-206

  Zhang, Zhang Jin ^a,b   Lappi, Douglas A ^c   Wrenn, Craige C ^a,d   Milner, Teresa A ^e   Wiley, Ronald G ^a,b  

^a Laboratory of Experimental Neurology   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c Advanced Targeting Systems   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Department of Obstetrics Gynecology   (United States)

Author keywords

Alzheimer's disease; Cholinergic basal forebrain; Cortex; Immunotoxin lesion; Neuropeptide Y; Rat; Somatostatin

Indexed keywords

ACETYLCHOLINESTERASE; IMMUNOTOXIN; NEUROPEPTIDE Y; NEUROTROPHIN RECEPTOR; SAPORIN; SOMATOSTATIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CHOLINERGIC SYSTEM; CONTROLLED STUDY; FOREBRAIN; FRONTAL CORTEX; MALE; NERVE CELL DEGENERATION; NONHUMAN; OCCIPITAL CORTEX; PARIETAL LOBE; PRIORITY JOURNAL; RAT;

ACETYLCHOLINESTERASE; ANIMALS; ANTIBODIES; CELL COUNT; CELL DEATH; CHOLINERGIC FIBERS; FRONTAL LOBE; IMMUNOHISTOCHEMISTRY; IMMUNOTOXINS; MALE; NEUROPEPTIDE Y; OCCIPITAL LOBE; PARIETAL LOBE; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; SOMATOSTATIN;

EID: 0032480003     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00484-3     Document Type: Article

References (39)

1. Arendash G.W., Millard W.J., Dunn A.J., Meyer E.M. Long-term neuropathological and neurochemical effects of nucleus basalis lesions in the rat. Science. 238:1987;952-956.
2. Baxter M.G., Bucci D.J., Gorman L.K., Wiley R.G., Gallagher M. Selective immunotoxic lesions of basal forebrain cholinergic cells: effects on learning and memory in rats. Behav. Neurosci. 109:1995;714-722.
3. Beal M.F., Mazurek M.F., Svendsen C.N., Bird E.D., Martin J.B. Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease. Ann. Neurol. 20:1986;282-286.
4. Cha C.I., Lee Y., Lee E.Y., Park K.H., Baik S.H. Age-related changes of VIP, NPY and somatostatin-immunoreactive neurons in the cerebral cortex of aged rats. Brain Res. 753:1997;235-244.
5. Connor D.J., Langlais P.J., Thal L.J. Behavioral impairments after lesions of the nucleus basalis by ibotenic acid and quisqualic acid. Brain Res. 555:1991;84-90.
6. Davies P., Katzman R., Terry R.D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer's disease and Alzheimer senile dementia. Nature. 288:1980;279-280.
7. de Quidt M.E., Emson P.C. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system: II. Immunohistochemical analysis. Neuroscience. 18:1986;545-618.
8. Dunnett S.B., Everitt B.J., Robbins T.W. The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions. Trends Neurosci. 14:1991;494-501.
9. Dunnett S.B., Whishaw I.Q., Jones G.H., Bunch S.T. Behavioral, biochemical and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats. Neuroscience. 20:1987;653-669.
10. Ferrier I.N., Leake A. Peptides in the neocortex in Alzheimer's disease and aging. Psychoneuroendocrinology. 15:1990;89-95.
11. Finley J.C., Maderdrut J.L., Roger L.J., Petrusz P. The immunocytochemical localization of somatostatin-containing neurons in the rat central nervous system. Neuroscience. 6:1981;2173-2192.
12. Florio T., Ventra C., Postiglione A., Schettini G. Age-related alterations of somatostatin gene expression in different rat brain areas. Brain Res. 557:1991;64-68.
13. Gaykema R.P.A., Gaàl G., Traber J., Hersh L.B., Luiten P.G.M. The basal forebrain cholinergic system: efferent and afferent connectivity and long-term effects of lesions. Acta Psychiatr. Scand. 366:1991;14-26. (Suppl.).
14. Gsell W., Strein I., Riederer P. The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared. J. Neural Transm. 47:1996;73-101. (Suppl.).
15. Heckers S., Ohtake T., Wiley R.G., Lappi D.A., Geula C.G., Mesulam M.-M. Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor. J. Neurosci. 14:1994;1271-1289.
16. Hendry S., Jones E., Emson P. Morphology, distribution and synaptic relations of somatostatin and neuropeptide Y immunoreactive neurons in rat and monkey neocortex. J. Neurosci. 4:1984;2497-2517.
17. Higuchi H., Nakano K., Iwasa A. Decrease in prepro-neuropeptide Y gene expression in the adrenal gland and cerebral cortex of spontaneously hypertensive rats. Neuropeptides. 25:1993;343-349.
18. Kowalski C., Micheau J., Corder R., Gaillard R., Conte-Devoix B. Age-related changes in corticotrophin-releasing factor, somatostatin, neuropeptide Y, methionine enkephalin and β-endorphin in specific rat brain areas. Brain Res. 582:1992;38-46.
19. Lamour Y., Epelbaum J. Interactions between cholinergic and peptidergic systems in the cerebral cortex and hippocampus. Prog. Neurobiol. 31:1988;109-148.
20. Leanza G., Nilsson O.G., Wiley R.G., Björklund A. Selective lesioning of the basal forebrain cholinergic system by intraventricular 192 IgG saporin: behavioral, biochemical and stereological studies in the rat. Eur. J. Neurosci. 7:1995;329-343.
21. Lo Conte G., Bartolini L., Casamenti F., Marconcini-Pepeu I., Pepeu G. Lesions of cholinergic forebrain nuclei: changes in avoidance behavior and scopolamine actions. Pharmacol. Biochem. Behav. 17:1982;933-937.
22. Martinez-Guijarro F.J., Freund T.F. GABA-immunoreactive basal forebrain afferents innervate GABA-immunoreactive non-pyramidal cells in the cerebral cortex of the lizard Podarcis hispanica. Neuroscience. 51:1992;425-437.
23. Matsuoka N., Yamazaki M., Yamaguchi I. Changes in brain somatostatin in memory-deficient rats: comparison with cholinergic markers. Neuroscience. 66:1995;617-626.
24. Milner T.A., Wiley R.G., Kurucz O.S., Prince S.R., Pierce J.P. Selective changes in hippocampal neuropeptide Y neurons following removal of the cholinergic septal inputs. J. Comp. Neurol. 386:1997;46-59.
25. J.E. Morley, J.F. Flood, Effects of NPY on memory processing and ingestive behaviours, in: V. Mutt (Ed.), Neuropeptide Y, Raven Press, New York, 1989, pp. 303-311.
26. Moyse E., Szigethy E., Danger J.M., Vaudry H., Wenk G., Beaudet A., Epelbaum J. Short- and long-term effects of nucleus basalis magnocellularis lesions on cortical levels of somatostatin and its receptors in the rat. Brain Res. 607:1993;154-160.
27. Mufson E.J., Kehr A.D., Wainer B.H., Mesulam M.-M. Cortical effects of neurotoxic damage to the nucleus basalis in rats: persistent loss of extrinsic cholinergic input and lack of transsynaptic effect upon the number of somatostatin-containing, cholinesterase-positive, and cholinergic cortical neurons. Brain Res. 417:1987;385-388.
28. Nilsson L., Winblad B., Bergstrom L. Diminution of preprosomatostatin-mRNA in cerebral cortex of the aged rat. Neurochem. Int. 27:1995;481-487.
29. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, San Diego, 1986.
30. Rossor M.N., Emson P.C., Mountjoy C.Q., Roth, Sir M., Iversen L.L. Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type. Neurosci. Lett. 20:1980;373-377.
31. Sonntag W.E., Boyd R.L., Booze R.M. Somatostatin gene expression in hypothalamus and cortex of aging male rats. Neurobiol. Aging. 11:1990;409-416.
32. Tago H., Kimura H., Maeda T. Visualization of detailed acetylcholinesterase fiber and neuron staining in rat brain by a sensitive histochemical procedure. J. Histochem. Cytochem. 34:1986;1431-1438.
33. Unger J.W., Schmidt Y. Neuropeptide Y and somatostatin in the neocortex of young and aging rats: response to nucleus basalis lesions. J. Chem. Neuroanat. 7:1994;25-34.
34. Wiley R.G. Neural lesioning with ribosome-inactivating proteins: suicide transport and immunolesioning. Trends Neurosci. 15:1992;285-290.
35. Wiley R.G., Berbos T.G., Deckwerth T.L., Johnson E.M. Jr., Lappi D.A. Destruction of the cholinergic basal forebrain using immunotoxin to rat NGF receptor: modeling the cholinergic degeneration of Alzheimer's disease. J. Neurol. Sci. 128:1995;157-166.
36. R.G. Wiley, D.A. Lappi, Preparation of anti-neuronal immunotoxins to selective neural immunolesioning, Neurosci. Protocols, 93-020-02 (1993) 1-12.
37. R.G. Wiley, D.A. Lappi, Suicide Transport and Immunolesioning, R.G. Landes, Austin, 1994, pp. 101-104.
38. Wiley R.G., Oeltmann T.N., Lappi D.A. Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor. Brain Res. 562:1991;149-153.
39. Zhang Z.-J., Berbos T.G., Wrenn C.C., Wiley R.G. Loss of nucleus basalis magnocellularis, but not septal, cholinergic neurons correlates with passive avoidance impairment in rats treated with 192-saporin. Neurosci. Lett. 203:1996;214-218.